Carlos J Cara

Summary

Affiliation: Celltech R and D Ltd
Country: UK

Publications

  1. ncbi [Hypomethylation and multiple sclerosis, the susceptibility factor?]
    C J Cara Terribas
    Celltech Pharma España, Departamento Cientifico, Madrid, Spain
    Neurologia 17:132-5. 2002
  2. ncbi Reviewing the mechanism of action of thiopurine drugs: towards a new paradigm in clinical practice
    Carlos J Cara
    Scientific Department, Celltech Pharma, Madrid, Spain
    Med Sci Monit 10:RA247-54. 2004

Collaborators

Detail Information

Publications2

  1. ncbi [Hypomethylation and multiple sclerosis, the susceptibility factor?]
    C J Cara Terribas
    Celltech Pharma España, Departamento Cientifico, Madrid, Spain
    Neurologia 17:132-5. 2002
    ..The TPMT activity frequency distribution histogram from a Spanish population sample has been compared with the corresponding ones to Crohn's disease, ulcerative colitis and MS patients...
  2. ncbi Reviewing the mechanism of action of thiopurine drugs: towards a new paradigm in clinical practice
    Carlos J Cara
    Scientific Department, Celltech Pharma, Madrid, Spain
    Med Sci Monit 10:RA247-54. 2004
    ..Our final proposal suggests that the immunosuppressive effects of these drugs are due to a balanced combination of antimetabolic and pro-apoptotic actions...